Clinical Trial Update: ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ELIOS investigating investigational biomarkers to track disease modification in active Relapsing Remitting Multiple Sclerosis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | Phase 4 | Status: RECRUITING